
CurifyLabs presents the Pharmaprinter Aurum for manufacturing personalized drugs
The Finnish company CurifyLabs has launched a new 3D printing system called Pharmaprinter Aurum. This equipment is specifically designed so that pharmacies and hospitals can prepare medications tailored to each patient locally. 🏥
A system that combines precision and speed
The Pharmaprinter Aurum uses additive manufacturing technology to produce tablets. It employs an injection head that deposits liquid drugs onto a powder bed, which then solidifies. This process allows precise control of the amount of active ingredient in each tablet and the combination of multiple medications into a single unit. The company claims it can generate small batches more agilely than conventional drug compounding methods in a pharmacy. ⚡
Key advantages of the technology:- Allows adjusting doses with great precision for each patient.
- Ability to integrate multiple drugs into a single tablet.
- Streamlines the process of making medications for complex treatments.
This method aims to transform how medications requiring very specific dosages are dispensed.
Impact on pharmaceutical management
By enabling on-demand production directly at the point of care, the Pharmaprinter Aurum seeks to optimize logistics. The goal is to reduce the inventory that pharmacies must store and minimize the waste of leftover medications. This is especially useful for pediatric, geriatric, or oncology patients, who often need doses that laboratories do not produce in a standard way. 💊
Logistical benefits:- Reduces the need to maintain a large stock of specialized medications.
- Reduces drug waste by producing only what is necessary.
- Facilitates more immediate access to personalized treatments.
The future of automation in pharmacy
The arrival of this technology marks a significant step toward personalized medicine. By streamlining the creation of custom pharmaceutical compounds, it not only optimizes the pharmacist's work but also improves patient treatment adherence. The next logical challenge in this evolution would be to integrate the process even further, making the medication experience complete and efficient. 🚀